MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Febuxostat

Febuxostat 80mg tablets

Compatible

Stability notes for Febuxostat 80mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Adenuric 80mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Suppliers (14) of Febuxostat 80mg tablets
Adenuric 80mg tablets (A. Menarini Farmaceutica Internazionale SRL)
Adenuric 80mg tablets (CST Pharma Ltd)
Adenuric 80mg tablets (Lexon (UK) Ltd)
Elstabya 80mg tablets (Amarox Ltd)
Febuxostat 80mg tablets (A A H Pharmaceuticals Ltd)
Febuxostat 80mg tablets (Alliance Healthcare (Distribution) Ltd)
Febuxostat 80mg tablets (Crescent Pharma Ltd)
Febuxostat 80mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Febuxostat 80mg tablets (Macleods Pharma UK Ltd)
Febuxostat 80mg tablets (Manx Healthcare Ltd)
Febuxostat 80mg tablets (Medihealth (Northern) Ltd)
Febuxostat 80mg tablets (Milpharm Ltd)
Febuxostat 80mg tablets (MSN Laboratories Europe Ltd)
Febuxostat 80mg tablets (Tillomed Laboratories Ltd)

Febuxostat 120mg tablets

Compatible

Stability notes for Febuxostat 120mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Adenuric 120mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Suppliers (10) of Febuxostat 120mg tablets
Adenuric 120mg tablets (A. Menarini Farmaceutica Internazionale SRL)
Elstabya 120mg tablets (Amarox Ltd)
Febuxostat 120mg tablets (A A H Pharmaceuticals Ltd)
Febuxostat 120mg tablets (Alliance Healthcare (Distribution) Ltd)
Febuxostat 120mg tablets (Crescent Pharma Ltd)
Febuxostat 120mg tablets (Macleods Pharma UK Ltd)
Febuxostat 120mg tablets (Medihealth (Northern) Ltd)
Febuxostat 120mg tablets (Milpharm Ltd)
Febuxostat 120mg tablets (MSN Laboratories Europe Ltd)
Febuxostat 120mg tablets (Tillomed Laboratories Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.